home / stock / apyx / apyx news


APYX News and Press, Apyx Medical Corporation From 03/21/24

Stock Information

Company Name: Apyx Medical Corporation
Stock Symbol: APYX
Market: NASDAQ
Website: apyxmedical.com

Menu

APYX APYX Quote APYX Short APYX News APYX Articles APYX Message Board
Get APYX Alerts

News, Short Squeeze, Breakout and More Instantly...

APYX - PHIO and MGRM among healthcare movers

2024-03-21 10:12:15 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...

APYX - US Companies Moving the Markets, Morning edition
Thu, Mar 21, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Yield10 Bioscience Inc. (YTEN) rose 135.5% to $0.5722 on volume of 57,300,938 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 8.7% to $3.16 on volume of 30,926,102 shares Kaival Brands Innovations Group Inc. (KAVL) rose...

APYX - Apyx Medical reports mixed Q4 results; initiates FY24 outlook

2024-03-21 07:23:03 ET More on Apyx Medical Apyx stock rises on publication of Renuvion safety analysis Apyx Medical's Q4 revenue to be below consensus Seeking Alpha’s Quant Rating on Apyx Medical Historical earnings data for Apyx Medical Finan...

APYX - Expected US Company Earnings on Thursday, March 21st, 2024

X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...

APYX - Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Advanced Energy Sales increased 15% year-over-year and 23% quarter-over-quarter in the fourth quarter; increased 18% year-over-year in 2023 Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium ...

APYX - Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Apyx ® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the fourth quarter and fiscal year 2023 will be re...

APYX - Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Presentation hosted by Dr. Michael Kluska to feature the results of a retrospective clinical study comparing the use of Renuvion to a competing technology when used in conjunction with liposuction or body contouring, demonstrating significantly fewer adverse events Apyx Medical Corporat...

APYX - IRDM, ENVX and HTOO are among after hour movers

2024-02-20 16:59:25 ET Gainers: Apyx Medical  ( APYX ) +8% . Intuitive Machines ( LUNR ) +6% . Enovix Corporation ( ENVX ) +6% . Iridium Communications ( IRDM ) +3% . Halozyme Therapeutics ( HALO ) +3% . Losers: Sola...

APYX - Apyx stock rises on publication of Renuvion safety analysis

2024-01-22 16:20:27 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript Apyx Medical's Q4 revenue to be below consensus Apyx Medical appoints Matthew Hill as CFO Seeking Alpha’s Quant Rating on Apyx Medical ...

APYX - Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Analysis of data from 483 patients with a total of 1,184 body areas treated found the use of Renuvion for subcutaneous soft tissue contraction following liposuction demonstrated no new or increased risks for any area of the body, compared to the use of liposuction alone Apyx Medical Cor...

Previous 10 Next 10